These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9462431)

  • 21. Activity of cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa and Burkholderia cepacia group strains and isolates.
    Livermore DM; Mushtaq S; Ge Y; Warner M
    Int J Antimicrob Agents; 2009 Nov; 34(5):402-6. PubMed ID: 19428220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia.
    Gutmann L; Williamson R; Moreau N; Kitzis MD; Collatz E; Acar JF; Goldstein FW
    J Infect Dis; 1985 Mar; 151(3):501-7. PubMed ID: 2982966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia.
    Aaron SD; Ferris W; Henry DA; Speert DP; Macdonald NE
    Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1206-12. PubMed ID: 10764313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful salvage therapy with tigecycline and trimethoprim/sulfamethoxazole for recurrent osteomyelitis caused by Burkholderia cepacia.
    Lee WS; Hsieh TC; Ou TY; Chen FL; Yu FL; Jean SS; Hsu CW
    J Microbiol Immunol Infect; 2017 Feb; 50(1):123-124. PubMed ID: 25649488
    [No Abstract]   [Full Text] [Related]  

  • 25. Exploring the Role of the Ω-Loop in the Evolution of Ceftazidime Resistance in the PenA β-Lactamase from Burkholderia multivorans, an Important Cystic Fibrosis Pathogen.
    Papp-Wallace KM; Becka SA; Taracila MA; Zeiser ET; Gatta JA; LiPuma JJ; Bonomo RA
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of outer membrane proteins and peroxide-sensor genes in Burkholderia cepacia resistance to isothiazolone.
    Zhou G; Shi QS; Ouyang YS; Chen YB
    World J Microbiol Biotechnol; 2014 Apr; 30(4):1251-60. PubMed ID: 24197783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitization of Burkholderia cepacia to antibiotics by cationic drugs.
    Rajyaguru JM; Muszynski MJ
    J Antimicrob Chemother; 1998 Feb; 41(2):277-80. PubMed ID: 9533472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burkholderia cepacia septicemia in a pediatric oncology patient: a pharmacotherapy challenge.
    Durham SH; Lee AE; Assanasen C
    Ann Pharmacother; 2012 Jun; 46(6):e16. PubMed ID: 22570430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced expression of outer-membrane proteins in beta-lactam-resistant mutants of Enterobacter cloacae.
    Aggeler R; Then RL; Ghosh R
    J Gen Microbiol; 1987 Dec; 133(12):3383-92. PubMed ID: 3503923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipopolysaccharide alterations responsible for combined quinolone and beta-lactam resistance in Pseudomonas aeruginosa.
    Leying HJ; Büscher KH; Cullmann W; Then RL
    Chemotherapy; 1992; 38(2):82-91. PubMed ID: 1591950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating the role of matrix components in protection of Burkholderia cepacia complex biofilms against tobramycin.
    Messiaen AS; Nelis H; Coenye T
    J Cyst Fibros; 2014 Jan; 13(1):56-62. PubMed ID: 23932109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria.
    Peeters E; Nelis HJ; Coenye T
    J Antimicrob Chemother; 2009 Oct; 64(4):801-9. PubMed ID: 19633000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outer membrane changes in Pseudomonas stutzeri resistant to chlorhexidine diacetate and cetylpyridinium chloride.
    Tattawasart U; Maillard JY; Furr JR; Russell AD
    Int J Antimicrob Agents; 2000 Nov; 16(3):233-8. PubMed ID: 11091041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unusual interaction of a lipopolysaccharide isolated from Burkholderia cepacia with polymyxin B.
    Shimomura H; Matsuura M; Saito S; Hirai Y; Isshiki Y; Kawahara K
    Infect Immun; 2003 Sep; 71(9):5225-30. PubMed ID: 12933868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli.
    Moreno E; Prats G; Sabaté M; Pérez T; Johnson JR; Andreu A
    J Antimicrob Chemother; 2006 Feb; 57(2):204-11. PubMed ID: 16390858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment.
    Dance DA; Wuthiekanun V; Chaowagul W; White NJ
    J Antimicrob Chemother; 1989 Sep; 24(3):295-309. PubMed ID: 2681116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibacterial properties of investigational, new, and commonly used antibiotics against isolates of Pseudomonas cepacia in Michigan.
    Bhakta DR; Leader I; Jacobson R; Robinson-Dunn B; Honicky RE; Kumar A
    Chemotherapy; 1992; 38(5):319-23. PubMed ID: 1283733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subspecific differentiation of Burkholderia cepacia isolates in cystic fibrosis.
    Livesley MA; Baxter IA; Lambert PA; Govan JR; Weller PH; Lacey DE; Allison DG; Giwercman B; Hoiby N
    J Med Microbiol; 1998 Nov; 47(11):999-1006. PubMed ID: 9822299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substituted amines synergistic with tobramycin against Burkholderia cepacia in vitro.
    Cohn RC; Rudzienski L
    Chemotherapy; 1997; 43(2):100-7. PubMed ID: 9084918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluoroquinolone-resistant mutants of Burkholderia cepacia.
    Pope CF; Gillespie SH; Pratten JR; McHugh TD
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1201-3. PubMed ID: 18160522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.